by LIVIUS Editorial | Dec 14, 2025 | Business Update
LIVIUS’s science-driven commercial products continue to serve as real-world validation of our technology platform. Insights generated through these applications inform ongoing research and development activities, reinforcing a continuous feedback loop between science...
by LIVIUS Editorial | Dec 7, 2025 | Research Update
LIVIUS continues to advance its cellular reprogramming platform based on miRNA biology, small-molecule epigenetic control, and DNA repair mechanisms. Current efforts are focused on strengthening platform robustness and supporting early discovery and preclinical...
by LIVIUS Editorial | Dec 1, 2025 | Company Update
LIVIUS is beginning a structured approach to external communications, sharing selected updates on our technology platform, research activities, and business progress. Information will be released periodically as it becomes appropriate for public disclosure, in...
